189 related articles for article (PubMed ID: 24999633)
1. Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan.
Huang HL; Kung PT; Chiu CF; Wang YH; Tsai WC
PLoS One; 2014; 9(7):e101731. PubMed ID: 24999633
[TBL] [Abstract][Full Text] [Related]
2. Characteristics, survival, and related factors of newly diagnosed colorectal cancer patients refusing cancer treatments under a universal health insurance program.
Liu CY; Chen WT; Kung PT; Chiu CF; Wang YH; Shieh SH; Tsai WC
BMC Cancer; 2014 Jun; 14():446. PubMed ID: 24938667
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the Delayed or Refusal Therapy in Breast Cancer Patients: A Longitudinal Population-Based Study in Taiwan.
Chen SJ; Kung PT; Huang KH; Wang YH; Tsai WC
PLoS One; 2015; 10(6):e0131305. PubMed ID: 26114875
[TBL] [Abstract][Full Text] [Related]
4. Predicting mortality of incident dialysis patients in Taiwan--a longitudinal population-based study.
Wu PH; Lin YT; Lee TC; Lin MY; Kuo MC; Chiu YW; Hwang SJ; Chen HC
PLoS One; 2013; 8(4):e61930. PubMed ID: 23626754
[TBL] [Abstract][Full Text] [Related]
5. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
Yang CC; Fong Y; Lin LC; Que J; Ting WC; Chang CL; Wu HM; Ho CH; Wang JJ; Huang CI
Eur J Cardiothorac Surg; 2018 Jan; 53(1):235-240. PubMed ID: 29106506
[TBL] [Abstract][Full Text] [Related]
6. Decision to adopt medical technology under the National Health Insurance System in Taiwan: case study of new molecular targeted drugs among non-small cell lung cancer patients.
Chen HL; Shen LJ; Wei CP; Lu HM; Hsiao FY
J Eval Clin Pract; 2015 Oct; 21(5):808-16. PubMed ID: 26096761
[TBL] [Abstract][Full Text] [Related]
7. Effect of time interval from diagnosis to treatment for non-small cell lung cancer on survival: a national cohort study in Taiwan.
Tsai CH; Kung PT; Kuo WY; Tsai WC
BMJ Open; 2020 Apr; 10(4):e034351. PubMed ID: 32327476
[TBL] [Abstract][Full Text] [Related]
8. Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.
Lu PW; Fields AC; Yoo J; Irani J; Goldberg JE; Bleday R; Melnitchouk N
J Surg Oncol; 2020 Jun; 121(8):1306-1313. PubMed ID: 32227344
[TBL] [Abstract][Full Text] [Related]
9. Effects of continuity of care on the postradiotherapy survival of working-age patients with oral cavity cancer: A nationwide population-based cohort study in Taiwan.
Kuo TJ; Wu PC; Tang PL; Yin CH; Chu CH; Hung YM
PLoS One; 2019; 14(12):e0225635. PubMed ID: 31841525
[TBL] [Abstract][Full Text] [Related]
10. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers.
Johnson SB; Park HS; Gross CP; Yu JB
JAMA Oncol; 2018 Oct; 4(10):1375-1381. PubMed ID: 30027204
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan.
Chiang JK; Kao YH; Lai NS
PLoS One; 2015; 10(9):e0138773. PubMed ID: 26406871
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
[TBL] [Abstract][Full Text] [Related]
13. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
Rice SR; Vyfhuis MAL; Scilla KA; Burrows WM; Bhooshan N; Suntharalingam M; Edelman MJ; Feliciano J; Badiyan SN; Simone CB; Bentzen SM; Feigenberg SJ; Mohindra P
Clin Lung Cancer; 2020 May; 21(3):e130-e141. PubMed ID: 31708388
[TBL] [Abstract][Full Text] [Related]
14. Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: a cohort study in Taiwan.
Chang CH; Lee CH; Ko JC; Chang LY; Lee MC; Wang JY; Yu CJ
Cancer Med; 2017 Jul; 6(7):1563-1572. PubMed ID: 28639751
[TBL] [Abstract][Full Text] [Related]
15. Impact of universal health coverage on suicide risk in newly diagnosed cancer patients: Population-based cohort study from 1985 to 2007 in Taiwan.
Lin PH; Liao SC; Chen IM; Kuo PH; Shan JC; Lee MB; Chen WJ
Psychooncology; 2017 Nov; 26(11):1852-1859. PubMed ID: 28181332
[TBL] [Abstract][Full Text] [Related]
16. Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
Duma N; Idossa DW; Durani U; Frank RD; Paludo J; Westin G; Lou Y; Mansfield AS; Adjei AA; Go RS; Ailawadhi S
Clin Lung Cancer; 2020 May; 21(3):e115-e129. PubMed ID: 31570228
[TBL] [Abstract][Full Text] [Related]
17. Factors involved in the delay of treatment initiation for cervical cancer patients: A nationwide population-based study.
Shen SC; Hung YC; Kung PT; Yang WH; Wang YH; Tsai WC
Medicine (Baltimore); 2016 Aug; 95(33):e4568. PubMed ID: 27537583
[TBL] [Abstract][Full Text] [Related]
18. Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan.
Kao WH; Hong JH; See LC; Yu HP; Hsu JT; Chou IJ; Chou WC; Chiou MJ; Wang CC; Kuo CF
Pharmacoepidemiol Drug Saf; 2018 Oct; 27(10):1060-1066. PubMed ID: 28815803
[TBL] [Abstract][Full Text] [Related]
19. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study.
Hung KF; Hsu CP; Chiang JH; Lin HJ; Kuo YT; Sun MF; Yen HR
J Ethnopharmacol; 2017 Mar; 199():168-174. PubMed ID: 28163114
[TBL] [Abstract][Full Text] [Related]
20. Treatment and mortality risk of older adults with non-small cell cancer in Taiwan: A population-based cohort study.
Wang CC; Chiu SW; Wu SJ; Pan LK; Yen YF; Lai YJ; Chen CC
Thorac Cancer; 2023 Sep; 14(26):2687-2695. PubMed ID: 37551918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
